AI Designs the Switch; the Cell Decides #Shorts

What if the future of gene therapy were not about changing DNA, but teaching it when to speak?

Artificial intelligence can already propose small fragments of DNA called enhancers. They do not make proteins: they act as controls that indicate which cells should activate a gene, when, and how strongly.

In the laboratory, thousands of these sequences were tested in different cell lines. Some showed activity and specificity: they worked better in some cells than in others. They even succeeded in reactivating the AXIN2 gene in its natural genomic environment, a particularly interesting result.

But the machine only makes proposals. A sequence that works in a cell culture is not yet a safe therapy for a person. The challenge will be to test its stability, dosage, and behavior in real tissues.

AI is beginning to design the switches. The cell still has the final say.

Full episode: https://youtu.be/VOqKWSdp2E0

🤖 AI-generated content: the script, voices, and images in this episode were produced using artificial intelligence tools.

#Shorts